PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank57
Year-over-Year Change
Profit from core business operations before interest and taxes
Latest
$-4.38M
↑ 14% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-5.08M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-4.38M | +32.9% |
| 2024 | $-6.52M | -1.0% |
| 2023 | $-6.46M | -47.0% |
| 2022 | $-4.39M | -21.2% |
| 2021 | $-3.62M | +5.3% |
| 2020 | $-3.83M | +6.7% |
| 2019 | $-4.10M | +41.3% |
| 2018 | $-6.98M | -57.2% |
| 2017 | $-4.44M | +26.9% |
| 2016 | $-6.07M | - |